Matthew L. Posard
Director · 2 filings · Latest: Jun 18, 2026
HALOZYME THERAPEUTICS, INC.
Nautilus Biotechnology, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|
Director · 2 filings · Latest: Jun 18, 2026
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|